Fiera Capital (Canada)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fiera Capital (Canada)’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-738,858	Closed	-$8.77M	–	726
2017 Q2	$8.77M	Sell	738,858 -583,354	-44%	-$7.26M	0.04%	250
2017 Q1	$19.5M	Sell	1,322,212 -97,589	-7%	-$1.58M	0.1%	184
2016 Q4	$23M	Sell	1,419,801 -284,255	-17%	-$5.15M	0.13%	166
2016 Q3	$30.9M	Sell	1,704,056 -50,155	-3%	-$980K	0.17%	143
2016 Q2	$28.9M	Buy	+1,754,211	New	+$28.4M	0.16%	156

Other funds holding HZNP

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Fiera Capital (Canada)'s HZNP Position: Q3 2017 in Review

Fiera Capital (Canada) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2017, closing a stake of 738,858 shares — an estimated $8.77M sold.

Fiera Capital (Canada) first reported a position in HZNP in Q2 2016 and held it in 5 quarters. The position peaked at $30.9M in Q3 2016. 181 funds tracked by Wall St. Rank hold HZNP as of Q3 2017.

Fiera Capital (Canada) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Fiera Capital (Canada) sold 738,858 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2017, an estimated $8.77M.
Fiera Capital (Canada) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and held it in 5 quarters.
Fiera Capital (Canada)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $30.9M in Q3 2016.
181 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2017, filed 13 Nov 2017.